214 related articles for article (PubMed ID: 20032116)
1. Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis.
Zhang J; Noble NA; Border WA; Huang Y
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F579-88. PubMed ID: 20032116
[TBL] [Abstract][Full Text] [Related]
2. Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis.
Zhang J; Gu C; Noble NA; Border WA; Huang Y
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F723-32. PubMed ID: 21795644
[TBL] [Abstract][Full Text] [Related]
3. A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.
Huang Y; Haraguchi M; Lawrence DA; Border WA; Yu L; Noble NA
J Clin Invest; 2003 Aug; 112(3):379-88. PubMed ID: 12897205
[TBL] [Abstract][Full Text] [Related]
4. Effect of adrenotensin on cell proliferation is mediated by angiotensin II in cultured rat mesangial cells.
Xue H; Yuan P; Zhou L; Yao T; Huang Y; Lu LM
Acta Pharmacol Sin; 2009 Aug; 30(8):1132-7. PubMed ID: 19597528
[TBL] [Abstract][Full Text] [Related]
5. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.
Huang Y; Wongamorntham S; Kasting J; McQuillan D; Owens RT; Yu L; Noble NA; Border W
Kidney Int; 2006 Jan; 69(1):105-13. PubMed ID: 16374430
[TBL] [Abstract][Full Text] [Related]
6. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
7. Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis.
Huang Y; Border WA; Lawrence DA; Noble NA
Kidney Int; 2006 Aug; 70(3):515-22. PubMed ID: 16788698
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
Naito T; Ma LJ; Yang H; Zuo Y; Tang Y; Han JY; Kon V; Fogo AB
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F683-91. PubMed ID: 20042458
[TBL] [Abstract][Full Text] [Related]
9. Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect.
Yu L; Border WA; Anderson I; McCourt M; Huang Y; Noble NA
Kidney Int; 2004 Nov; 66(5):1774-84. PubMed ID: 15496148
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats.
Kim CS; Kim IJ; Bae EH; Ma SK; Lee J; Kim SW
PLoS One; 2015; 10(11):e0142664. PubMed ID: 26556707
[TBL] [Abstract][Full Text] [Related]
12. Effects of exendin-4 on the intrarenal renin-angiotensin system and interstitial fibrosis in unilateral ureteral obstruction mice: Exendin-4 and unilateral ureteral obstruction.
Le Y; Zheng Z; Xue J; Cheng M; Guan M; Xue Y
J Renin Angiotensin Aldosterone Syst; 2016 Oct; 17(4):. PubMed ID: 27913661
[TBL] [Abstract][Full Text] [Related]
13. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated nonproteolytic activation of prorenin and induction of TGF-β1 and PAI-1 expression in renal mesangial cells.
Zhang J; Wu J; Gu C; Noble NA; Border WA; Huang Y
Am J Physiol Renal Physiol; 2012 Jul; 303(1):F11-20. PubMed ID: 22535800
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of angiotensin-(1-7) administrated with an angiotensin-receptor blocker in a rat model of chronic kidney disease.
Xu C; Ding W; Zhang M; Gu Y
Nephrology (Carlton); 2013 Dec; 18(12):761-9. PubMed ID: 23901805
[TBL] [Abstract][Full Text] [Related]
16. H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation.
Xue H; Yuan P; Ni J; Li C; Shao D; Liu J; Shen Y; Wang Z; Zhou L; Zhang W; Huang Y; Yu C; Wang R; Lu L
PLoS One; 2013; 8(9):e74366. PubMed ID: 24058553
[TBL] [Abstract][Full Text] [Related]
17. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells.
Huang Y; Noble NA; Zhang J; Xu C; Border WA
Kidney Int; 2007 Jul; 72(1):45-52. PubMed ID: 17396111
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.
Peters H; Border WA; Noble NA
Kidney Int; 2000 Apr; 57(4):1493-501. PubMed ID: 10760085
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
[TBL] [Abstract][Full Text] [Related]
20. t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis.
Haraguchi M; Border WA; Huang Y; Noble NA
Kidney Int; 2001 Jun; 59(6):2146-55. PubMed ID: 11380816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
